Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in HIV-1 antibody research using humanized mice.

Henning Gruell1, Florian Klein

  • 1aInstitute of Virology, University Hospital Cologne bLaboratory of Experimental Immunology, Center for Molecular Medicine Cologne (CMMC), University of Cologne cDepartment I of Internal Medicine, University Hospital Cologne dGerman Center for Infection Research, partner site Bonn-Cologne, Cologne, Germany.

Current Opinion in HIV and AIDS
|April 20, 2017
PubMed
Summary

Broadly neutralizing antibodies show promise for preventing and treating HIV-1. Humanized mouse models are crucial for testing these antibodies in vivo, advancing HIV-1 prevention and therapy research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical assessment of broadly neutralizing HIV-1 antibody BNT351 with optimized pharmacokinetics and potent antiviral activity.

iScience·2026
Same author

Protocol for multiplexed detection of antibody binding to cell-surface-expressed hemagglutinin by flow cytometry.

STAR protocols·2026
Same author

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

Nature immunology·2026
Same author

Time-series clustering analysis reveals distinct patterns of cytomegalovirus viremia in critically ill adults.

Intensive care medicine experimental·2026
Same author

Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitope.

Nature immunology·2026
Same author

Pre-existing neutralizing antibodies against cattle-transmitted influenza A virus H5N1 are detectable in unexposed individuals.

Immunity·2026

Area of Science:

  • Immunology
  • Virology
  • Preclinical Research

Background:

  • Broadly neutralizing antibodies (bNAbs) offer new avenues for HIV-1 prevention, treatment, and cure.
  • Humanized mouse models are essential for in vivo evaluation of bNAbs.

Purpose of the Study:

  • To review recent findings on bNAbs in humanized mice.
  • To assess the potential of bNAbs for HIV-1 prevention and therapy in humans.

Main Methods:

  • Utilizing humanized mouse models to test bNAb efficacy in vivo.
  • Investigating antibody-mediated prevention and therapy approaches.
  • Analyzing immunization strategies in transgenic mice for bNAb induction.

Main Results:

  • Humanized mice demonstrated the in vivo antiviral efficacy of HIV-1 bNAbs.

Related Experiment Videos

  • Antibody combinations suppressed HIV-1 viremia and targeted the viral reservoir.
  • Passive antibody administration and vector-mediated production protected mice from infection.
  • Immunization studies informed potential vaccination strategies for inducing potent bNAbs.

    • Conclusions:

    • Humanized mouse models are invaluable for HIV-1 research.
    • These models facilitate the investigation of novel HIV-1 prevention and therapy strategies.
    • Humanized mice expedite the translation of basic research findings to clinical applications.